Skip to content
OpenCapital
Get started

Zoetis ZTS Contract manufacturing & human health — Revenue

Other product segments

Horses
$5.8B+13.9%
Dogs and Cats
$1.35B+11.6%
Parasiticides
$586M+2.4%
Vaccines
$519M+18.2%
Cattle
$399M-0.5%
Dermatology
$349M-7.9%
Anti-infectives
$241M+1.3%
Pain and sedation
$203M-1.9%
Other pharmaceutical
$158M0.0%
Swine
$128M-7.9%
Animal health diagnostics
$117M+12.5%
Poultry
$117M-7.9%
Other Non Pharmaceuticals
$66M-7.0%
Fish
$65M+4.8%
Sheep and other
$17M+6.3%

Similar metrics at other companies

Veracyte logo
VCYTContract manufacturing and testing — Total Revenue
$0-100%
Elanco Animal Health Inc. logo
ELANContract Manufacturing — Revenue
$19M+58.3%
Biogen logo
BIIBContract manufacturing revenue — Total Revenue
$237.2M-16.0%
Biogen logo
BIIBContract manufacturing, royalty and other revenue — Revenue
$183.23M+12.3%
Biogen logo
BIIBContract manufacturing, royalty and other revenue — Total Revenue
$246.9M-15.8%
Phibro Animal Health logo
PAHCAnimal Health — Revenue
$291.23M+12.7%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$31.9B-54.6%
Enterprise value$39.95B-47.2%
P/E12.1×-15.1×
P/S3.4×-4.1×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's contract manufacturing & human health — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's contract manufacturing & human health — revenue?
Zoetis (ZTS) reported contract manufacturing & human health — revenue of $23M in Q1 2026.
How has Zoetis's contract manufacturing & human health — revenue changed year-over-year?
Zoetis's contract manufacturing & human health — revenue decreased by 23.3% year-over-year, from $30M to $23M.
What is the long-term trend for Zoetis's contract manufacturing & human health — revenue?
Over 4 years (2021 to 2025), Zoetis's contract manufacturing & human health — revenue has grown at a 9.3% compound annual growth rate (CAGR), from $82M to $117M.
What does contract manufacturing & human health — revenue mean?
This metric represents the total revenue generated from contract manufacturing services provided to third parties and the sale of human health diagnostic products. It captures income streams outside of the core animal health portfolio, reflecting the company's utilization of its manufacturing infrastructure and diagnostic capabilities for external partners. This segment serves as a secondary revenue driver that leverages existing technical expertise and production capacity.